The Prospecive OBSERVational Munich Interventional MITRAl-Valve Registry

Deutsches Herzzentrum Muenchen1 site in 1 country5,000 target enrollmentSeptember 15, 2020

ConditionsMitral Valve Regurgitation Mitral Valve Stenosis Tricuspid Valve Regurgitation

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Mitral Valve Regurgitation
Sponsor: Deutsches Herzzentrum Muenchen
Enrollment: 5000
Locations: 1
Primary Endpoint: Long-term mortality
Status: Recruiting
Last Updated: 5 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Prospective, single-center observational registry including all consecutive patients treated with transcatheter mitral or tricuspid valve therapy at the Deutsches Herzzentrum München, Germany.

Detailed Description

Long-term mortality after transcatheter mitral or tricuspid valve therapy

Registry

clinicaltrials.gov

Start Date

September 15, 2020

End Date

January 1, 2031

Last Updated

5 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Deutsches Herzzentrum Muenchen

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Age above 18 years and consentable
•Mitral Valve Regurgitation, Mitral Valve Stenosis, Tricuspid Valve Regurgitation, Tricuspid Stenosis
•Transcatheter mitral or tricuspid valve therapy considered best option by heart-team decision
•Written informed consent